CN112638878B - 制备阿卡拉布替尼的方法 - Google Patents
制备阿卡拉布替尼的方法Info
- Publication number
- CN112638878B CN112638878B CN201980055726.6A CN201980055726A CN112638878B CN 112638878 B CN112638878 B CN 112638878B CN 201980055726 A CN201980055726 A CN 201980055726A CN 112638878 B CN112638878 B CN 112638878B
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- salt
- vii
- reaction medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B63/00—Purification; Separation; Stabilisation; Use of additives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202510979992.5A CN120904205A (zh) | 2018-08-29 | 2019-08-28 | 制备阿卡拉布替尼的方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724228P | 2018-08-29 | 2018-08-29 | |
| US62/724228 | 2018-08-29 | ||
| PCT/EP2019/072991 WO2020043787A1 (en) | 2018-08-29 | 2019-08-28 | Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202510979992.5A Division CN120904205A (zh) | 2018-08-29 | 2019-08-28 | 制备阿卡拉布替尼的方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112638878A CN112638878A (zh) | 2021-04-09 |
| CN112638878B true CN112638878B (zh) | 2025-07-22 |
Family
ID=67928802
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201980055726.6A Active CN112638878B (zh) | 2018-08-29 | 2019-08-28 | 制备阿卡拉布替尼的方法 |
| CN202510979992.5A Pending CN120904205A (zh) | 2018-08-29 | 2019-08-28 | 制备阿卡拉布替尼的方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202510979992.5A Pending CN120904205A (zh) | 2018-08-29 | 2019-08-28 | 制备阿卡拉布替尼的方法 |
Country Status (16)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| EP3947386A1 (en) * | 2019-03-27 | 2022-02-09 | Assia Chemical Industries Ltd | Solid state forms of acalabrutinib |
| DK4054582T3 (da) | 2019-11-04 | 2025-12-01 | Astrazeneca Ab | Terapeutiske kombinationer af acalabrutinib og capivasertib til behandling af b-celle-maligniteter |
| CR20230018A (es) | 2020-06-19 | 2023-04-11 | Acerta Pharma Bv | Formas farmacéuticas de maleato de acalabrutinib |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018115965A1 (en) * | 2016-12-23 | 2018-06-28 | Acerta Pharma Bv | Solid forms of imidazopyrazine compounds |
| CN108250186A (zh) * | 2018-02-07 | 2018-07-06 | 杭州科巢生物科技有限公司 | Acalabrutinib及其中间体的合成方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2372694T3 (es) | 2003-10-15 | 2012-01-25 | OSI Pharmaceuticals, LLC | Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina. |
| EP2139487B1 (en) | 2007-03-28 | 2015-11-11 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
| US8765754B2 (en) | 2009-04-29 | 2014-07-01 | Locus Pharmaceuticals, Inc. | Pyrrolotriazine compounds |
| US8658794B2 (en) | 2010-02-08 | 2014-02-25 | Merck Sharp & Dohme B.V. | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof |
| CN103889987B (zh) * | 2011-07-19 | 2016-09-14 | 默沙东有限责任公司 | 作为btk抑制剂的选择的咪唑并吡嗪类 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| WO2014113942A1 (en) | 2013-01-23 | 2014-07-31 | Merck Sharp & Dohme Corp. | Btk inhibitors |
| MX362181B (es) | 2013-02-19 | 2019-01-08 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa del receptor de tropomiosina (trk). |
| US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| WO2016128912A1 (en) | 2015-02-12 | 2016-08-18 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, a pd-1 inhibitor, and/or a pd-l1 inhibitor |
| IL293821A (en) | 2015-07-02 | 2022-08-01 | Acerta Pharma Bv | Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-aminoyl)pyrrolidine-2-yl)imidazo[5,1-yl]pyrazin-1-yl)-en- (pyridine-2-yl)benzamide |
| WO2017077507A1 (en) * | 2015-11-06 | 2017-05-11 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of bruton's tyrosine kinase |
| CN107056786B (zh) | 2016-10-14 | 2019-05-07 | 苏州明锐医药科技有限公司 | 阿卡替尼的制备方法 |
| ES2856248T3 (es) | 2016-12-21 | 2021-09-27 | Acerta Pharma Bv | Inhibidores de imidazopirazina de la tirosina quinasa de Bruton |
| CN106588937B (zh) | 2017-01-16 | 2018-09-21 | 东莞市真兴贝特医药技术有限公司 | 咪唑并吡嗪类化合物及其制备方法和应用 |
| US10899770B2 (en) | 2017-02-20 | 2021-01-26 | Hangzhou Solipharma Co., Ltd. | Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof |
| US10800787B2 (en) | 2017-04-20 | 2020-10-13 | Apotex Inc. | Process for the preparation of acalabrutinib |
| CN107522701B (zh) | 2017-09-01 | 2019-11-08 | 苏州富士莱医药股份有限公司 | 一种治疗慢性淋巴细胞白血病的BTK抑制剂Acalabrutinib的合成方法 |
| US11161851B2 (en) | 2017-11-06 | 2021-11-02 | Suzhou Pengxu Pharmatech Co. Ltd. | Processes to produce acalabrutinib |
| WO2019239374A1 (en) | 2018-06-13 | 2019-12-19 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of interleukin-2-inducible t-cell kinase |
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| WO2020085504A1 (ja) | 2018-10-26 | 2020-04-30 | 大鵬薬品工業株式会社 | 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法 |
-
2019
- 2019-08-28 KR KR1020257025628A patent/KR20250119664A/ko active Pending
- 2019-08-28 BR BR112021003480-3A patent/BR112021003480A2/pt unknown
- 2019-08-28 IL IL281025A patent/IL281025B2/en unknown
- 2019-08-28 CN CN201980055726.6A patent/CN112638878B/zh active Active
- 2019-08-28 KR KR1020217008606A patent/KR102842131B1/ko active Active
- 2019-08-28 IL IL312413A patent/IL312413B2/en unknown
- 2019-08-28 EA EA202190557A patent/EA202190557A1/ru unknown
- 2019-08-28 EP EP19766195.2A patent/EP3844149A1/en active Pending
- 2019-08-28 CN CN202510979992.5A patent/CN120904205A/zh active Pending
- 2019-08-28 MA MA053485A patent/MA53485A/fr unknown
- 2019-08-28 MY MYPI2021000982A patent/MY206899A/en unknown
- 2019-08-28 CA CA3109734A patent/CA3109734A1/en active Pending
- 2019-08-28 WO PCT/EP2019/072991 patent/WO2020043787A1/en not_active Ceased
- 2019-08-28 MX MX2021002246A patent/MX2021002246A/es unknown
- 2019-08-28 JP JP2021536157A patent/JP7439095B2/ja active Active
- 2019-08-28 US US17/271,750 patent/US12024520B2/en active Active
- 2019-08-28 AU AU2019332882A patent/AU2019332882B2/en active Active
- 2019-08-28 IL IL322382A patent/IL322382A/en unknown
-
2021
- 2021-02-25 MX MX2023011692A patent/MX2023011692A/es unknown
- 2021-03-23 CO CONC2021/0003676A patent/CO2021003676A2/es unknown
-
2022
- 2022-02-09 AU AU2022200828A patent/AU2022200828B2/en active Active
-
2023
- 2023-06-20 ZA ZA2023/06381A patent/ZA202306381B/en unknown
- 2023-07-13 AU AU2023204660A patent/AU2023204660B2/en active Active
- 2023-12-18 JP JP2023212753A patent/JP7829541B2/ja active Active
-
2024
- 2024-04-10 AU AU2024202290A patent/AU2024202290A1/en not_active Abandoned
- 2024-05-09 US US18/659,338 patent/US12448387B2/en active Active
- 2024-12-09 ZA ZA2024/09391A patent/ZA202409391B/en unknown
-
2025
- 2025-09-12 US US19/326,835 patent/US20260109701A1/en active Pending
- 2025-10-21 JP JP2025176881A patent/JP2026021364A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018115965A1 (en) * | 2016-12-23 | 2018-06-28 | Acerta Pharma Bv | Solid forms of imidazopyrazine compounds |
| CN108250186A (zh) * | 2018-02-07 | 2018-07-06 | 杭州科巢生物科技有限公司 | Acalabrutinib及其中间体的合成方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7829541B2 (ja) | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス | |
| TWI770120B (zh) | 有機碘化化合物、一鍋法製備有機碘化化合物之方法及有機碘化化合物之用途 | |
| HK40041702A (en) | Processes for the preparation of acalabrutinib | |
| HK40041702B (en) | Processes for the preparation of acalabrutinib | |
| KR101694262B1 (ko) | 실로도신의 결정형의 제조방법 | |
| EA049170B1 (ru) | СПОСОБ ПОЛУЧЕНИЯ 4-{8-АМИНО-3-[(2S)-2-ПИРРОЛИДИНИЛ]ИМИДАЗО[1,5-a]ПИРАЗИН-1-ИЛ}-N-(2-ПИРИДИНИЛ)БЕНЗАМИДА | |
| EA043329B1 (ru) | СПОСОБЫ ПОЛУЧЕНИЯ 4-{8-АМИНО-3-[(2S)-1-(БУТ-2-ИНОЛ)ПИРРОЛИДИН-2-ИЛ]ИМИДАЗО[1,5-a]ПИРАЗИН-1-ИЛ}-N-(ПИРИДИН-2-ИЛ)БЕНЗАМИДА | |
| IL312472A (en) | Evaluation system, evaluation method and evaluation software | |
| KR101733084B1 (ko) | 실로도신의 결정형의 제조방법 | |
| JP2025083072A (ja) | ボルチオキセチンの製造方法 | |
| JP2026058357A (ja) | イミダゾピリジノン化合物の製造方法及び中間体 | |
| HK40117121A (en) | Methods and intermediates for preparing 2-[(4-{6-[(4-cyano-2-fluorobenzyl)oxy]pyridin-2-yl}piperidin-1-yl)methyl]-1-[(2s)-oxetan-2-ylmethyl]-1h-benzimidazole-6-carboxylic acid, 1,3-dihydroxy-2-(hydroxymethyl)propan-2-amine salt | |
| JP2004075616A (ja) | 4−ハロゲノ−2−(4−フルオロフェニルアミノ)−5,6−ジメチルピリミジンの製造方法 | |
| KR20220064248A (ko) | Trk 억제제 화합물의 제조 방법 | |
| HK40035144B (en) | Preparation process of two compounds | |
| JP2000143601A (ja) | ヒドラゾン誘導体の製造法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40041702 Country of ref document: HK |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TG01 | Patent term adjustment |
Free format text: NEW EXPIRY DATE: 20400123 |
|
| TG01 | Patent term adjustment |